74 related articles for article (PubMed ID: 10323381)
21. Insulin resistance in cirrhosis: prolonged reduction of hyperinsulinemia normalizes insulin sensitivity.
Petrides AS; Stanley T; Matthews DE; Vogt C; Bush AJ; Lambeth H
Hepatology; 1998 Jul; 28(1):141-9. PubMed ID: 9657106
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin does not alter insulin-mediated glucose disposal.
Meneilly GS; Elahi D; Minaker KL; Rowe JW
J Clin Endocrinol Metab; 1987 Aug; 65(2):364-7. PubMed ID: 2885337
[TBL] [Abstract][Full Text] [Related]
23. A comparison of insulin suppression tests performed with somatostatin and octreotide with particular reference to tolerability.
Hwu CM; Kwok CF; Chiang SC; Wang PY; Hsiao LC; Lee SH; Lin SH; Ho LT
Diabetes Res Clin Pract; 2001 Mar; 51(3):187-93. PubMed ID: 11269891
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of insulin resistance in non-obese subjects with impaired glucose tolerance.
Ratzmann KP; Witt S; Schulz B
Diabete Metab; 1982 Sep; 8(3):223-8. PubMed ID: 6754494
[TBL] [Abstract][Full Text] [Related]
25. Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance.
Dorella M; Giusto M; Da Tos V; Campagnolo M; Palatini P; Rossi G; Ceolotto G; Felice M; Semplicini A; Del Prato S
J Clin Endocrinol Metab; 1996 Apr; 81(4):1568-74. PubMed ID: 8636369
[TBL] [Abstract][Full Text] [Related]
26. Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations.
Rosolová H; Mayer O; Reaven GM
Metabolism; 2000 Mar; 49(3):418-20. PubMed ID: 10726923
[TBL] [Abstract][Full Text] [Related]
27. Insulin secretion and insulin action in Taiwanese with type 2 diabetes.
Shen DC; Kuo SW; Shian LR; Fuh MT; Wu DA; Chen YD; Reaven GM
Diabetes Res Clin Pract; 1988 Apr; 4(4):289-93. PubMed ID: 2897274
[TBL] [Abstract][Full Text] [Related]
28. [The somatostatin infusion test for the evaluation of glucose utilization in bezafibrate medication].
Vogelberg KH; Müller HJ; Hübinger A
Arzneimittelforschung; 1984; 34(9):1038-41. PubMed ID: 6150716
[TBL] [Abstract][Full Text] [Related]
29. Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals.
Su HY; Sheu WH; Chin HM; Jeng CY; Chen YD; Reaven GM
Am J Hypertens; 1995 Nov; 8(11):1067-71. PubMed ID: 8554729
[TBL] [Abstract][Full Text] [Related]
30. Insulin-mediated increase in blood flow is impaired in the elderly.
Meneilly GS; Elliot T; Bryer-Ash M; Floras JS
J Clin Endocrinol Metab; 1995 Jun; 80(6):1899-903. PubMed ID: 7775638
[TBL] [Abstract][Full Text] [Related]
31. Prolonged infusion of somatostatin with glucagon replacement increases plasma glucose and glucose turnover in man.
Ward WK; Best JD; Halter JB; Porte D
J Clin Endocrinol Metab; 1984 Mar; 58(3):449-53. PubMed ID: 6141177
[TBL] [Abstract][Full Text] [Related]
32. Three months energy restricted diet does not reduce peripheral insulin resistance in newly diagnosed non insulin dependent diabetics.
Walshe K; Andrews WJ; Sheridan B; Woods R; Hadden DR
Horm Metab Res; 1987 May; 19(5):197-200. PubMed ID: 3556373
[TBL] [Abstract][Full Text] [Related]
33. Use of a variable insulin infusion to assess insulin action in obesity: defects in both the kinetics and amplitude of response.
Doeden B; Rizza R
J Clin Endocrinol Metab; 1987 May; 64(5):902-8. PubMed ID: 3549759
[TBL] [Abstract][Full Text] [Related]
34. Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals.
Jones CN; Pei D; Staris P; Polonsky KS; Chen YD; Reaven GM
J Clin Endocrinol Metab; 1997 Jun; 82(6):1834-8. PubMed ID: 9177392
[TBL] [Abstract][Full Text] [Related]
35. Relation between insulin resistance and plasma concentrations of lipid hydroperoxides, carotenoids, and tocopherols.
Facchini FS; Humphreys MH; DoNascimento CA; Abbasi F; Reaven GM
Am J Clin Nutr; 2000 Sep; 72(3):776-9. PubMed ID: 10966898
[TBL] [Abstract][Full Text] [Related]
36. Insulin resistance in patients with essential hypertension can occur in the absence of microalbuminuria.
Yip JW; Jones C; Facchini F; Chen I; Reaven GM
Am J Hypertens; 1996 Oct; 9(10 Pt 1):959-63. PubMed ID: 8896647
[TBL] [Abstract][Full Text] [Related]
37. Resistance to insulin-mediated glucose uptake and hyperinsulinemia in women who had preeclampsia during pregnancy.
Fuh MM; Yin CS; Pei D; Sheu WH; Jeng CY; Chen YI; Reaven GM
Am J Hypertens; 1995 Jul; 8(7):768-71. PubMed ID: 7546505
[TBL] [Abstract][Full Text] [Related]
38. Somatostatin does not increase insulin-stimulated glucose uptake in humans.
Baron AD; Wallace P; Brechtel G; Prager R
Diabetes; 1987 Jan; 36(1):33-6. PubMed ID: 2878848
[TBL] [Abstract][Full Text] [Related]
39. Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm.
Møller N; Bagger JP; Schmitz O; Jørgensen JO; Ovesen P; Møller J; Alberti KG; Orskov H
J Clin Endocrinol Metab; 1995 Jun; 80(6):1789-93. PubMed ID: 7775624
[TBL] [Abstract][Full Text] [Related]
40. Gemfibrozil treatment of endogenous hypertriglyceridemia: effect on insulin-mediated glucose disposal and plasma insulin concentrations.
Jeng CY; Sheu WH; Fuh MM; Shieh SM; Chen YD; Reaven GM
J Clin Endocrinol Metab; 1996 Jul; 81(7):2550-3. PubMed ID: 8675576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
